rare disease Blogs

03|04|26

Rare Disease in Focus: How Innovation Is Accelerating Access for Patients

The rare disease landscape has long been defined by delay, with families frequently facing 7–10 years before receiving a diagnosis. In recognition of Rare Disease Day, Ann Cave, President, Full-Service Agency, wrote an article for PM360 spotlighting how innovation and human insight are reshaping the rare disease landscape.

03|02|26

Creative That Connects: Earning Trust in Rare Disease Communities

In honor of Rare Disease Day, Patrick Brodfuehrer penned an article in Med Ad News that explores what authentic connection really means for the 300 million people worldwide living with a rare disease.  

02|28|25

Make a Difference in Rare Disease With Creativity, Data, and Innovation: Insights from Ann Cave

Learn the key takeaways and insights from a recent Med Ad News article about how to make a difference in rare disease marketing with creativity, data and innovation.

02|28|25

Rare but Prevalent: The Unequal Toll of Rare Diseases on Women

Learn how pharmaceutical companies can address gaps in women's health related to rare disease, and improve outcomes for patients.

02|20|25

Building Trust With Education and Innovation: Rare Disease Marketing

Rare and ultra-rare diseases face problems most brands do … turned up to 11. Budgets? Smaller. Patient pool? Even smaller. Healthcare providers (HCPs) who understand the condition? Sometimes even smaller than that. Treatment options can be limited, access can be hard to find and diagnosis time can sometimes be measured in decades rather than months. […]

10|10|23

Move Over, White Whales – Zebras Are Here

Pharma has historically sought to find blockbuster drugs - the extremely popular drugs that elicit comparisons with the elusive white whale - but that has neglected "zebras," the symbol of rare disease. Fortunately, things are changing.